Spread of Artemisinin Resistance in Plasmodium falciparum Malaria

Title
Spread of Artemisinin Resistance in Plasmodium falciparum Malaria
Authors
Ashley, EA; Dhorda, M; Fairhurst, RM; Amaratunga, C; Lim, P; Suon, S; Sreng, S; Anderson, JM; Mao, S; Sam, B; Sopha, C; Chuor, CM; Nguon, C; Sovannaroth, S; Pukrittayakamee, S; Jittamala, P; Chotivanich, K; Chutasmit, K; Suchatsoonthorn, C; Runcharoen, R; Hien, TT; Thuy-Nhien, NT; Thanh, NV; Phu, NH; Htut, Y; Han, KT; Aye, KH; Mokuolu, OA; Olaosebikan, RR; Folaranmi, OO; Mayxay, M; Khanthavong, M; Hongvanthong, B; Newton, PN; Onyamboko, MA; Fanello, CI; Tshefu, AK; Mishra, N; Valecha, N; Phyo, AP; Nosten, F; Yi, P; Tripura, R; Borrmann, S; Bashraheil, M; Peshu, J; Faiz, MA; Ghose, A; Hossain, MA; Samad, R; Rahman, MR; Hasan, MM; Islam, A; Miotto, O; Amato, R; MacInnis, B; Stalker, J; Kwiatkowski, DP; Bozdech, Z; Jeeyapant, A; Cheah, PY; Sakulthaew, T; Chalk, J; Intharabut, B; Silamut, K; Lee, SJ; Vihokhern, B; Kunasol, C; Imwong, M; Tarning, J; Taylor, WJ; Yeung, S; Woodrow, CJ; Flegg, JA; Das, D; Smith, J; Venkatesan, M; Plowe, CV; Stepniewska, K; Guerin, PJ; Dondorp, AM; Day, NP; White, NJ
Keywords
PARASITE CLEARANCE; WESTERN CAMBODIA; SUSCEPTIBILITY; ARTESUNATE; EFFICACY; PROVINCE; RATES
Issue Date
2014
Publisher
NEW ENGL J MED
Citation
NEW ENGL J MED;N. Engl. J. Med.;31-Jul;2014;371;5
Abstract
BACKGROUND Artemisinin resistance in Plasmodium falciparum has emerged in Southeast Asia and now poses a threat to the control and elimination of malaria. Mapping the geographic extent of resistance is essential for planning containment and elimination strategies. METHODS Between May 2011 and April 2013, we enrolled 1241 adults and children with acute, uncomplicated falciparum malaria in an open-label trial at 15 sites in 10 countries (7 in Asia and 3 in Africa). Patients received artesunate, administered orally at a daily dose of either 2 mg per kilogram of body weight per day or 4 mg per kilogram, for 3 days, followed by a standard 3-day course of artemisinin-based combination therapy. Parasite counts in peripheral-blood samples were measured every 6 hours, and the parasite clearance half-lives were determined. RESULTS The median parasite clearance half-lives ranged from 1.9 hours in the Democratic Republic of Congo to 7.0 hours at the Thailand-Cambodia border. Slowly clearing in-fections (parasite clearance half-life >5 hours), strongly associated with single point mutations in the nullpropellernull region of the P. falciparum kelch protein gene on chromosome 13 (kelch13), were detected throughout mainland Southeast Asia from southern Vietnam to central Myanmar. The incidence of pretreatment and post-treatment gametocytemia was higher among patients with slow parasite clearance, suggesting greater potential for transmission. In western Cambodia, where artemisinin-based combination therapies are failing, the 6-day course of antimalarial therapy was associated with a cure rate of 97.7% (95% confidence interval, 90.9 to 99.4) at 42 days. CONCLUSIONS Artemisinin resistance to P. falciparum, which is now prevalent across mainland Southeast Asia, is associated with mutations in kelch13. Prolonged courses of artemisinin-based combination therapies are currently efficacious in areas where standard 3-day treatments are failing. (Funded by the U. K. Department of International Development and others; ClinicalTrials.gov number, NCT01350856.)
URI
http://hdl.handle.net/11267/2316
ISSN
0028-4793
Appears in Collections:
3.University of Health Sciences > Faculty of postgraduate > Journal articles
Files in This Item:

qrcode

Items in LAOSpace are protected by copyright, with all rights reserved, unless otherwise indicated.